Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer

Department of Chemistry, University of Michigan, Ann Arbor, USA.
Nano Letters (Impact Factor: 13.59). 01/2009; 8(12):4593-6. DOI: 10.1021/nl8029114
Source: PubMed


X-ray based computed tomography (CT) is among the most convenient imaging/diagnostic tools in hospitals today in terms of availability, efficiency, and cost. However, in contrast to magnetic resonance imaging (MRI) and various nuclear medicine imaging modalities, CT is not considered a molecular imaging modality since targeted and molecularly specific contrast agents have not yet been developed. Here we describe a targeted molecular imaging platform that enables, for the first time, cancer detection at the cellular and molecular level with standard clinical CT. The method is based on gold nanoprobes that selectively and sensitively target tumor selective antigens while inducing distinct contrast in CT imaging (increased X-ray attenuation). We present an in vitro proof of principle demonstration for head and neck cancer, showing that the attenuation coefficient for the molecularly targeted cells is over 5 times higher than for identical but untargeted cancer cells or for normal cells. We expect this novel imaging tool to lead to significant improvements in cancer therapy due to earlier detection, accurate staging, and microtumor identification.

Download full-text


Available from: James Balter, Sep 27, 2015
  • Source
    • "Moreover, the toxicity of GNPs has been shown to depend on the size, surface area, composition and shape of the nanomaterial (Abdelhalim and Mady 2011). Possible applications of GNPs include in vivo molecular imaging, photo-thermal therapy and DNA labelling (Popovtzer et al. 2008; Abdelhalim and Moussa 2013; Khan et al. 2014). Nanotechnology-based drug delivery systems have shown considerable potential for treatment of diseases such as cancer (Park 2007; Jain et al. 2012; Raghavendra et al. 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is a complex metabolic disease of excessive fat accumulation. It is a worldwide epidemic affecting billions of people. Current pharmacological treatment of obesity remains limited and ineffective due to systemic drug toxicity and undesirable side effects. The current epidemic raises a serious need for development of safer drugs to treat obesity. Nanotechnology-based drug delivery system for administering pharmaceutical compound to achieve therapeutic effects is currently an exciting field in cancer treatment. Drug delivery involves either modification of drug release profile, absorption, distribution and/or elimination, for the benefit of improving drug efficacy and safety. Therefore, nanotechnology holds promise in the treatment of diseases including obesity. Gold nanoparticles (GNPs) functionalised with different biomolecules have been successfully used as drug delivery, labelling and imaging tools in biomedical research. In this study, the binding-specificity and targeting ability of adipose homing peptide (AHP)-functionalised GNPs (AHP-GNPs) were evaluated using flow cytometry and inductively coupled plasma-optical emission spectroscopy. Caco-2 cells and rats fed either chow or a high-fat diet were treated with either unfunctionalised GNPs or AHP-GNPs. Cellular uptake of GNPs was detected in cells treated with AHP-GNPs and not those treated with GNPs alone. Binding of AHP to cells was both temperature- and concentration-dependent. Compared to rats treated with GNPs alone, treatment of obese rats with AHP-GNPs resulted in the targeted delivery of the GNPs to the white adipose tissue (WAT). This paper reports the successful targeting of AHP-functionalised GNPs to WAT of obese rats.
    Full-text · Article · Feb 2015 · Journal of Nanoparticle Research
  • Source
    • "PEG-NPs, however, often accumulate near tumors but do not penetrate into the tumor mass [11] [12], and some drugs cannot easily diffuse from PEG-NPs to cancer cells [13]. Chemical conjugation of specific ligands to PEG- NPs can increase tumor retention and intracellular uptake [14], with concomitant improvement in therapeutic efficacy [15] [16] and imaging sensitivity [17] [18]. However, chemical linkage of targeting ligands to PEG-NPs has some unsolved problems. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Methoxy PEGylated nanoparticles (mPEG-NPs) are increasingly used for cancer imaging and therapy. Here we describe a general and simple approach to confer tumor tropism to any mPEG-NP. We demonstrate this approach with humanized bispecific antibodies (BsAbs) that can bind to both mPEG molecules on mPEG-NPs and to EGFR or HER2 molecules overexpressed on the surface of cancer cells. Simple mixing of BsAbs with mPEG-NPs can mediate preferential binding of diverse mPEG-NPs to cancer cells that overexpress EGFR or HER2 under physiological conditions and significantly increase cancer cell killing by liposomal doxorubicin to EGFR(+) and HER2(+) cancer cells. BsAbs modification also enhanced accumulation of fluorescence-labeled NPs and significantly increased the anticancer activity of drug-loaded NPs to antigen-positive human tumors in a mouse model. Anti-mPEG BsAbs offer a simple one-step method to confer tumor specificity to mPEG-NPs for enhanced tumor accumulation and improved therapeutic efficacy.
    Full-text · Article · Sep 2014 · Biomaterials
  • Source
    • "Among the Au nanostructures, small sized Au nanoparticles (NPs) take more advantages to operate as X-ray CT contrast agents due to not only the high absorption coefficient of Xray but also the outstanding biocompatibility and easy urinary excretion, which ensure a relative complete clearance from body, avoid the concerns regarding the potential long-term toxicity [31]. Unfortunately, unlike the NIR absorbing Au nanostructures, such as Au nanoshells [4] [5], nanocages [6] [7] and nanorods [8] [9], Au nanoparticles usually have poor performances in PA imaging or PTT because of the very low absorption of light in NIR range [32]. Yet, the above NIR absorbing Au nanostructures have low photostability since their morphology and NIR absorption peak would diminish after a long period of laser irradiation due to the " melting effect " [33] [34]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The combination of CT imaging and photoacoustic (PA) imaging represents not only high resolution and ease of forming 3D visual image for locating tissues of interest, but also good soft tissue contrast and excellent high sensitivity, which is very beneficial to the precise guidance for photothermal therapy (PTT). The near infrared (NIR) absorbing Au nanostructures take advantages to operate as a CT contrast agent due to high absorption coefficient of X-ray and outstanding biocompatibility, but show obvious deficiency for PA imaging and PTT because of low photostability. Attacking this problem head on, the Au nanoparticles (NPs) were coated with Prussian blue (PB) which is a typical FDA-approved drug in clinic for safe and effective treatment of radioactive exposure. The obtained core/shell NPs of Au@PB NPs of 17.8 ± 2.3 nm were found to be an excellent photoabsorbing agent for both PTT and PA imaging due to high photostability and high molar extinction coefficient in NIR region. Their gold core of 9.1 ± 0.64 nm ensured a remarkable contrast enhancement for CT imaging. Through a one-time treatment of NIR laser irradiation after intravenous injection of Au@PB NPs, 100 mm3 sized tumors in nude mice could be completely ablated without recurrence. Such versatile nanoparticles integrating effective cancer diagnosis with noninvasive therapy might bring opportunities to future cancer therapy.
    Full-text · Article · Jul 2014 · Biomaterials
Show more